Tecan Group AG announced that Erik Norstrom has been appointed as Head of Corporate Development and a member of the Management Board. He will assume his new position at the company no later than December 1, 2017. Erik Norstrom held a number of Corporate Development and M&A positions with increasing management responsibility in the broader healthcare and medical technology industries. Since August 2015, he serves as Corporate Vice President, Business Development at Chr. Hansen Holding A/S, Denmark. From 2012 to 2015, Erik Norstrom was Head of Business Development and M&A at Nobel Biocare AG, Zurich. Prior to this, he was Head of M&A and Alliances at Nobel Biocare AG, Zurich (2008-2012), and before that he served as Corporate Development Director at F. Hoffmann-La Roche AG, Basel (2001-2008).